NPPA revokes its earlier direction refusing discontinuation of GSK's antifungal formulation: Gireesh Babu, New Delhi Saturday, November 8, 2025, 08:00 Hrs [IST] The National Pharm ...
Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
The plant-based API market is primed for growth due to heightened demand for sustainable, natural therapeutics and regulatory ...
The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...
Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...
Sun Pharmaceutical Industries clocked a net profit of ₹3,118 crore, for the second quarter ended September 30, up 2.6 per ...
Indian pharma’s strong fundamentals signal shift towards higher-margin, science-driven models: Bhavin Mehta: Nandita Vijayasimha, Bengaluru Monday, November 10, 2025, 08:00 Hrs ...
Pharmaceutical Dissolution Market Pharmaceutical Dissolution Market Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The ...
Aurobindo Pharma reported September quarter consolidated net profit rose nearly 4% to ₹848 crore compared with ₹817 crore a ...
Ahmedabad: Senores Pharma has announced the appointment and categorization of Manohar Lalge, President-Research and Development, as Senior Management Personnel of the Company.Manohar Lalge ...
To mitigate these challenges, it is critical to identify and implement an appropriate enabling formulation strategy early in the development process. Doing so can de-risk your program and reduce costs ...
Granules India advanced 2.04% to Rs 581.15 after the company announced that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its API Unit-I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback